Creutzfeldt-Jakob Disease with Corticobasal Syndrome-Like Onset: Case report
Objective: We present a 56-year-old man patient who diagnosed CJD with CBS-like onset. Background: Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized…Progressive supranuclear palsy presenting with corticobasal syndrome: a case report
Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS). Background: Underlying pathologies of CBS…Corticobasal degeneration and frontotemporal dementia – an overlapping continuum
Objective: This clinical case intends to highlight the continuum between frontotemporal dementia and corticobasal syndrome. Background: A substantive overlap between corticobasal degeneration and frontotemporal dementia…In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome
Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…Dextrometorphan/quinidine in Atypical Parkinsonisms and Huntington Disease
Objective: to determine whether Dextrometorphan/quinidine (DMQ) is effective in the treatment of PBA, AG or bulbar symptoms in corticobasal syndrome (CBS), multiple system atrophy (MSA),…Analysis of MAPT, GRN and C9orf72 genes in progressive supranuclear palsy, corticobasal syndrome and frontotemporal lobar degeneration in Russian population
Objective: To investigate MAPT variants and haplotypes, GRN mutations, and C9orf72 expansion in a cohort of Russian patients with progressive supranuclear palsy (PSP), cotricobasal syndrome…Tau PET in Parkinson syndromes. A new diagnostic tool?
Objective: To explore the potential of [F-18]-AV-1451 PET as a diagnostic tool in Parkinson plus syndromes. Background: Clinically, atypical Parkinson syndromes are often difficult to…Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms
Objective: The objective is to assess the use of the volumetry of OB & T as a parameter for distinguishing controls from patients with Parkinson's…Evaluation of the surface based measures to discriminate progressive supranuclear palsy from corticobasal syndrome
Objective: To evaluate structural gray matter (GM) changes tested by surface-based measures of cortical thickness (CTh), surface area (SA) and volume (VOL), in order to…A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project
Objective: To identify PSP/CBD progression biomarkers both to improve understanding of disease etiology and course, and to provide crucial tools to enhance the likelihood of…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- Next Page »